Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.

Authors:

Kevin Agostinucci Rebecca Hutcheson Sakib Hossain Jonathan V Pascale Elizabeth Villegas Frank Zhang Adeniyi Michael Adebesin John R Falck Sachin Gupte Victor Garcia Michal Laniado Schwartzman

J Hypertens 2022 03;40(3):498-511

Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York.

Objective: 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoactive eicosanoid exhibiting effects on vascular smooth muscle cell (VSMC) via G-protein coupled receptor 75 (GPR75) and include stimulation of contractility, migration, and growth. We examined whether VSMC-targeted overexpression of CYP4A12, the primary 20-HETE-producing enzyme in mice, is sufficient to promote hypertension.

Methods: Mice with VSM-specific Cyp4a12 overexpression (Myh11-4a12) and their littermate controls (WT) were generated by crossbreeding Cyp4a12-floxed with Myh11-Cre mice. The 20-HETE receptor blocker, N-disodium succinate-20-hydroxyeicosa-6(Z),15(Z)-diencarboxamide (AAA), was administered in the drinking water. Experiments were carried out for 12 days. SBP was measured by tail cuff. Renal interlobar and mesenteric arteries were harvested for assessment of gene expression, 20-HETE levels, vascular contractility, vasodilation, and remodeling.

Results: Vascular and circulatory levels of 20-HETE were several folds higher in Myh11-4a12 mice compared with WT. The Myh11-4a12 mice compared with WT were hypertensive (145 ± 2 vs. 127 ± 2 mmHg; P < 0.05) and their vasculature displayed a contractile phenotype exemplified by increased contractility, reduced vasodilatory capacity, and increased media to lumen ratio. All these features were reversed by the administration of AAA. The mechanism of increased contractility includes, at least in part, Rho-kinase activation followed by increased myosin light chain phosphorylation and activation of the contractile apparatus.

Conclusion: VSM-specific Cyp4a12 overexpression is sufficient to alter VSM cell phenotype through changes in contractile markers and enhancement in contractility that promote hypertension and vascular dysfunction in a 20-HETE-dependent manner. The 20-HETE receptor GPR75 may represent a novel target for the treatment of hypertension and associated vascular conditions.

Download full-text PDF	Source
http://dx.doi.org/10.1097/HJH.0000000000003038	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820380	PMC

March 2022

Publication Analysis

Keyword Occurance

Similar Publications

Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19.

Authors:

Meijia Gu Huaqin Pan Yuncong Yuan Xuemin Zhou Luojia Chen Xingran Wang Fang Fang Liu Hu Yaxuan Xie Chao Shen

Front Cell Infect Microbiol 2022 2;12:882661. Epub 2022 May 2.

College of Life Sciences, Wuhan University, Wuhan, China.

We have witnessed the 2-year-long global rampage of COVID-19 caused by the wide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, knowledge about biomarkers of the entire COVID-19 process is limited. Identification of the systemic features of COVID-19 will lead to critical biomarkers and therapeutic targets for early intervention and clinical disease course prediction. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Turn up the HETE on Septic Shock.

Authors:

Kirby Thomas Luke Strong Fan Fan Richard J Roman

J Cardiovasc Pharmacol 2022 May 13. Epub 2022 May 13.

Department of Pharmacology University of Mississippi Medical Center Jackson, MS 29216.

Abstract: Septic shock is life-threatening organ dysfunction due to a dysregulated response to infection. It is a leading cause of death caused by the excessive release of cytokines and inflammatory mediators in response to bacterial endotoxins. It produces hypotension refractory to vasoconstrictors leading to tissue hypoperfusion and multiple organ failure. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Upregulation of Beta 1 and Arachidonic acid Metabolizing Enzymes in the mouse Hearts and Kidneys after Sub chronic Administration of Rofecoxib.

Authors:

Noor Askar Yazun Jarrar Munir Gharaibeh Mohammad Alqudah

Curr Mol Pharmacol 2022 Apr 13. Epub 2022 Apr 13.

Department of Pathology & Microbiology, Faculty of Medicine & King Abdullah University Hospital, Jordan University of Science & Technology.

Background: An imbalance in the levels of arachidonic acid (ARA) metabolites in cardiovascular disorders and drug-induced cardiotoxicity have been previously described.

Aims: This study aimed to investigate the influence of cyclooxygenase-2 (COX-2) selective inhibitors on the gene expression of ARA-metabolizing genes and beta1 gene in the hearts and kidneys of experimental mice.

Methods: Thirty-five balb/c mice were divided into five groups with seven mice per group. Read More

View Article and Full-Text PDF

April 2022

Similar Publications

Effects of Erchen Decoction on Oxidative Stress-Related Cytochrome P450 Metabolites of Arachidonic Acid in Dyslipidemic Mice with Phlegm-Dampness Retention Syndrome: A Randomized, Controlled Trial on the Correspondence between Prescription and Syndrome.

Authors:

Jing Chen Chao Ye Zheng Yang Pinhui Li Hongfei Wu Bing Xu Shan Zhang Xiaolin Xue

Evid Based Complement Alternat Med 2022 29;2022:1079803. Epub 2022 Mar 29.

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Phlegm-dampness retention (PDR) syndrome is one of the main syndromes of dyslipidemia. This study investigated the effects of Erchen decoction (ECD) on concentrations of two oxidative stress-related cytochrome P450 (CYP450) metabolites of arachidonic acid-14,15-dihydroxyeicosatrienoic acid (14,15-DHET) and 20-hydroxyeicosatetraenoic acid (20-HETE)-in mice with dyslipidemia and phlegm-dampness retention (PDR) syndrome ( = 5 C57BL/6J mice and = 30 apolipoprotein E knockout mice). Murine models of the disease and syndrome were established using multifactor stimulation. Read More

View Article and Full-Text PDF

March 2022

Similar Publications

Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock.

Authors:

Bahar Tunctan Sefika Pinar Senol Meryem Temiz-Resitoglu Dilsah Ezgi Yilmaz Demet Sinem Guden Omer Bahceli Mehmet Furkan Horat Seyhan Sahan-Firat Ayse Nihal Sari John R Falck Raghunath Reddy Anugu Kafait U Malik

J Cardiovasc Pharmacol 2022 Mar 23. Epub 2022 Mar 23.

Department of Pharmacology, College of Medicine, University of Tennessee, Center for Health Sciences, Memphis, TN, USA.

Abstract: The orphan receptor, G protein-coupled receptor (GPR) 75, which has been shown to mediate various effects of 20-hydroxyeicosatetraenoic acid (20-HETE), is considered as a therapeutic target in the treatment of cardiovascular diseases in which changes in the production of 20-HETE play a key role in their pathogenesis. Our previous studies showed that 20-HETE mimetic, N-(20-hydroxyeicosa-5[Z],14[Z]-dienoyl)glycine (5,14-HEDGE), protects against vascular hyporeactivity, hypotension, tachycardia, and arterial inflammation induced by lipopolysaccharide (LPS) in rats. This study tested the hypothesis that the GPR75 signaling pathway mediates these effects of 5,14-HEDGE in response to systemic exposure to LPS. Read More

View Article and Full-Text PDF

March 2022

Similar Publications

}

Search Our Scientific Publications & Authors